NeoCutis Acknowledges Cultivating Skin Creams from Aborted Fetus

A cosmetics manufacturer admits that it is using aborted fetal cell lines in a line of anti-aging skin creams.

---

NeoCutis, a Switzerland-based bio-pharmaceutical company with offices in San Francisco, is using Processed Skin Cell Protein, or PSP, an ingredient developed from skin cells harvested from an aborted fetus. Some years ago scientists discovered that fetal skin has an ability to heal without scarring. PSP was developed by scientists at the University of Luasanne from the skin tissue of a 14-week male fetus donated by the University Hospital in Switzerland. They created a process to extract proteins from fetal cells and established a working cell bank to produce the human growth factor with the optimum balance of nutrients needed to restore aging skin. The company's website explains the origin of its PSP ingredient, culminating with the assurance that "No additional fetal biopsies will ever be required":

"A small biopsy of fetal skin was donated following a one-time medical termination and a dedicated cell bank was established for developing new skin treatments. Originally established for wound healing and burn treatments, today this same cell bank also provides a lasting supply of cells for producing Neocutis' proprietary skin care ingredient Processed Skin Cell Proteins."

Debi Vinnedge, executive director of Children of God for Life, is not comforted by company's assurance of no additional fetal biopsies:

"It is absolutely deplorable that Neocutis would resort to exploiting the remains of a deliberately slaughtered baby... as though the life of the one child... has no value." "What we don't know is how many other fetuses were involved before they perfected that one cell line. There's a possibility there were more," Vinnedge added.

Vinnedge is organizing a boycott of all NeoCutis products, beginning with the company's investors and offering free publicity to companies whose products are not derived from aborted fetal cell lines. NeoCutis may be contacted by phone 1-866-636-2884, by e-mail info@neocutis.com, or by using the on-line form at http://www.neocutis.com/contact.php.